Dr. James N. Moy, MD

Dr. Moy practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Moy's NPI, 1699700146, was assigned on July 12, 2006. Dr. Moy graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1984. Dr. Moy holds Illinois license 036-075005.

Dr. Moy's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Moy's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. The medical group on file is Rush University Internists. Dmand AI also links Dr. Moy to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moy practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatric allergy/immunology is Dr. Moy's primary specialty in the NPI Registry, under taxonomy code 2080P0201X. Dr. Moy is licensed in Illinois.

CMS data shows 41 Medicare services from Dr. Moy across 2 procedure codes in 2024, all of them office visits, for 57 Medicare patients. Medicare paid $3,918 for them.

CMS counts 57 Medicare patients who saw Dr. Moy in 2024. The largest group is 65 to 74, with 23 patients. 70% of them have high cholesterol, and 68% have high blood pressure. 40% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moy's median patient age at 40, with 62% women.

In 2024, Dr. Moy wrote 76 Medicare Part D claims for 30 patients. 63% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $1,165 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

Dr. Moy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moy as offering telehealth.

Dmand AI links 28 papers to Dr. Moy, published from 2018 to 2024. 2021 was the busiest year, with 7. The most frequent topics are COVID-19, SARS-CoV-2 and Antibodies, Viral. Dr. Moy has published most often in mBio. Dr. Moy's most frequent co-authors are Wanda Phipatanakul, MD, MS, Leonard B. Bacharier, MD and Ronina A. Covar, MD.

Dmand AI links Dr. Moy to 4 clinical trials. Conditions studied include Primary Immunodeficiency Diseases, Immunologic Deficiency Syndromes and Bruton type agammaglobulinemia. Octapharma sponsors the most, 2. Open Payments lists research payments to Dr. Moy that name 4 trials.

CMS Open Payments shows 13 general payments to Dr. Moy from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 35% of the total. Grifols Shared Services North America, Inc. paid the most, $3,660. It also lists 50 research payments totaling $55,737 from 2016 to 2021, naming 4 clinical trials.

Dr. Moy graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1984.